keyboard_arrow_up

U.S. Generic Drugs Industry 2015 illuminated by new report

U.S. Generic Drugs Industry 2015 Market Research Report is a new market research publication announced by Reportstack. This report is a professional and in-depth study on the current state of the Generic Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Generic Drugs market analysis is provided for the U.S. markets including development trends, competitive landscape analysis, and key regions development status. 

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Complete report available @ U.S. Generic Drugs Industry 2015 Market Research Report

The report focuses on U.S. major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Generic Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 161 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Snapshot of TOC with Companies Mentioned

Chapter Seven Analysis of Generic Drugs Industry Key Manufacturers 

7.1 Amneal Pharmaceuticals 
7.1.1 Company Profile 
7.1.2 Product Picture and Specification 
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.1.4 Amneal Pharmaceuticals SWOT Analysis

7.2 Actavis 
7.2.1 Company Profile 
7.2.2 Product Picture and Specification 
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.2.4 Actavis SWOT Analysis

7.3 Dr. Reddy's Laboratories 
7.3.1 Company Profile 
7.3.2 Product Picture and Specification 
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.3.4 Dr. Reddy's Laboratories SWOT Analysis

7.4 Endo International 
7.4.1 Company Profile 
7.4.2 Product Picture and Specification 
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.4.4 Endo International SWOT Analysis

7.5 Sandoz 
7.5.1 Company Profile 
7.5.2 Product Picture and Specification 
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.5.4 Sandoz SWOT Analysis

7.6 Pfizer 
7.6.1 Company Profile 
7.6.2 Product Picture and Specification 
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.6.4 Pfizer SWOT Analysis

7.7 Lupin 
7.7.1 Company Profile 
7.7.2 Product Picture and Specification 
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.7.4 Lupin SWOT Analysis

7.8 Mylan 
7.8.1 Company Profile 
7.8.2 Product Picture and Specification 
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.8.4 Mylan SWOT Analysis

7.9 Zydus Pharmaceuticals 
7.9.1 Company Profile 
7.9.2 Product Picture and Specification 
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.9.4 Zydus Pharmaceuticals SWOT Analysis

7.10 Teva Pharmaceuticals USA 
7.10.1 Company Profile 
7.10.2 Product Picture and Specification 
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 
7.10.4 Teva Pharmaceuticals USA SWOT Analysis 

Contact:

Debora White
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research